SCHEMBL17397366

SCHEMBL17397366

Cc1c(Br)cnn1Cc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
RECQL P46063 1/20 0.50
KDM4E B2RXH2 4/20 0.47
BRD4 O60885 1/20 0.46
HSD17B10 Q99714 1/20 0.44
PFKFB3 Q16875 1/20 0.44
GRM2 Q14416 1/20 0.44
POLB P06746 1/20 0.44
NPSR1 Q6W5P4 2/20 0.42
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
PPARG P37231 1/20 0.41
HTT P42858 1/20 0.41
NCOA2 Q15596 1/20 0.41
NCOA1 Q15788 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP19A1 P11511 1/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259540 0.81 TSHR (0.69) TSHRRECQLKDM4EBRD4HSD17B10
SCHEMBL4361457 0.80 TSHR (0.57) TSHRRECQLKDM4EBRD4HSD17B10
SCHEMBL23399007 0.79 TSHR (0.56) TSHRRECQLKDM4EBRD4HSD17B10
SCHEMBL26636843 0.79 TSHR (0.56) TSHRRECQLKDM4EBRD4HSD17B10
SCHEMBL25236370 0.79 TSHR (0.65) TSHRRECQLKDM4EBRD4HSD17B10
SCHEMBL17619656 0.79 TSHR (0.65) TSHRRECQLKDM4EBRD4HSD17B10
SCHEMBL31276324 0.77 RECQL (0.49) TSHRRECQLKDM4EHSD17B10GRM2
SCHEMBL21332851 0.77 TSHR (0.50) TSHRRECQLKDM4EBRD4HSD17B10
SCHEMBL4047300 0.76 ALDH1A1 (0.54) TSHRRECQLKDM4EHSD17B10PFKFB3
SCHEMBL21332896 0.76 TSHR (0.53) TSHRRECQLKDM4EBRD4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116547275-A IL-17A modulators 赛诺菲 2023-08-04 CN disclosed
US-20230227427-A1 IL-17A MODULATORS SANOFI (FR) 2023-07-20 US disclosed
EP-4157827-A1 IL-17A MODULATORS SANOFI (FR) 2023-04-05 EP disclosed
WO-2016000615-A1 HETEROARYL COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227427-A1 IL-17A MODULATORS IL17A, IL2, IL15 TSHR 2769/4885RECQL 4239/4885KDM4E 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.